MMQ Intrinsic Valuation and Fundamental Analysis - Mind Medicine (MindMed) Inc - Alpha Spread

Mind Medicine (MindMed) Inc
F:MMQ

Watchlist Manager
Mind Medicine (MindMed) Inc Logo
Mind Medicine (MindMed) Inc
F:MMQ
Watchlist
Price: 5.37 EUR -4.7% Market Closed
Market Cap: 386m EUR
Have any thoughts about
Mind Medicine (MindMed) Inc?
Write Note

Intrinsic Value

MMQ's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one MMQ stock under the Base Case scenario is 2.74 EUR. Compared to the current market price of 5.37 EUR, Mind Medicine (MindMed) Inc is Overvalued by 49%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MMQ Intrinsic Value
2.74 EUR
Overvaluation 49%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Mind Medicine (MindMed) Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MMQ cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MMQ?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Wall St Estimates
Price Target
Loading
Revenue Forecast
Operating Income Forecast
Earnings Forecast
No Indicators Selected
Select Indicators
Investor Returns
Shareholder Yield
Dividend Safety
Dividend Yield
Dividend Payout Ratio
Buyback Yield
Debt Paydown Yield
No Indicators Selected
Select Indicators
Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Mind Medicine (MindMed) Inc

Provide an overview of the primary business activities
of Mind Medicine (MindMed) Inc.

What unique competitive advantages
does Mind Medicine (MindMed) Inc hold over its rivals?

What risks and challenges
does Mind Medicine (MindMed) Inc face in the near future?

Summarize the latest earnings call
of Mind Medicine (MindMed) Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Mind Medicine (MindMed) Inc.

Provide P/S
for Mind Medicine (MindMed) Inc.

Provide P/E
for Mind Medicine (MindMed) Inc.

Provide P/OCF
for Mind Medicine (MindMed) Inc.

Provide P/FCFE
for Mind Medicine (MindMed) Inc.

Provide P/B
for Mind Medicine (MindMed) Inc.

Provide EV/S
for Mind Medicine (MindMed) Inc.

Provide EV/GP
for Mind Medicine (MindMed) Inc.

Provide EV/EBITDA
for Mind Medicine (MindMed) Inc.

Provide EV/EBIT
for Mind Medicine (MindMed) Inc.

Provide EV/OCF
for Mind Medicine (MindMed) Inc.

Provide EV/FCFF
for Mind Medicine (MindMed) Inc.

Provide EV/IC
for Mind Medicine (MindMed) Inc.

Show me price targets
for Mind Medicine (MindMed) Inc made by professional analysts.

What are the Revenue projections
for Mind Medicine (MindMed) Inc?

How accurate were the past Revenue estimates
for Mind Medicine (MindMed) Inc?

What are the Net Income projections
for Mind Medicine (MindMed) Inc?

How accurate were the past Net Income estimates
for Mind Medicine (MindMed) Inc?

What are the EPS projections
for Mind Medicine (MindMed) Inc?

How accurate were the past EPS estimates
for Mind Medicine (MindMed) Inc?

What are the EBIT projections
for Mind Medicine (MindMed) Inc?

How accurate were the past EBIT estimates
for Mind Medicine (MindMed) Inc?

Compare the revenue forecasts
for Mind Medicine (MindMed) Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Mind Medicine (MindMed) Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Mind Medicine (MindMed) Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Mind Medicine (MindMed) Inc compared to its peers.

Compare the P/E ratios
of Mind Medicine (MindMed) Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Mind Medicine (MindMed) Inc with its peers.

Analyze the financial leverage
of Mind Medicine (MindMed) Inc compared to its main competitors.

Show all profitability ratios
for Mind Medicine (MindMed) Inc.

Provide ROE
for Mind Medicine (MindMed) Inc.

Provide ROA
for Mind Medicine (MindMed) Inc.

Provide ROIC
for Mind Medicine (MindMed) Inc.

Provide ROCE
for Mind Medicine (MindMed) Inc.

Provide Gross Margin
for Mind Medicine (MindMed) Inc.

Provide Operating Margin
for Mind Medicine (MindMed) Inc.

Provide Net Margin
for Mind Medicine (MindMed) Inc.

Provide FCF Margin
for Mind Medicine (MindMed) Inc.

Show all solvency ratios
for Mind Medicine (MindMed) Inc.

Provide D/E Ratio
for Mind Medicine (MindMed) Inc.

Provide D/A Ratio
for Mind Medicine (MindMed) Inc.

Provide Interest Coverage Ratio
for Mind Medicine (MindMed) Inc.

Provide Altman Z-Score Ratio
for Mind Medicine (MindMed) Inc.

Provide Quick Ratio
for Mind Medicine (MindMed) Inc.

Provide Current Ratio
for Mind Medicine (MindMed) Inc.

Provide Cash Ratio
for Mind Medicine (MindMed) Inc.

What is the historical Revenue growth
over the last 5 years for Mind Medicine (MindMed) Inc?

What is the historical Net Income growth
over the last 5 years for Mind Medicine (MindMed) Inc?

What is the current Free Cash Flow
of Mind Medicine (MindMed) Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Mind Medicine (MindMed) Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mind Medicine (MindMed) Inc

Current Assets 247.7m
Cash & Short-Term Investments 243.1m
Other Current Assets 4.6m
Non-Current Assets 20.5m
Intangibles 19.9m
Other Non-Current Assets 534k
Current Liabilities 41.8m
Accounts Payable 2.9m
Accrued Liabilities 8.2m
Other Current Liabilities 30.7m
Non-Current Liabilities 24.3m
Long-Term Debt 24.3m
Efficiency

Earnings Waterfall
Mind Medicine (MindMed) Inc

Revenue
0 USD
Operating Expenses
-90.5m USD
Operating Income
-90.5m USD
Other Expenses
-11.6m USD
Net Income
-102m USD

Free Cash Flow Analysis
Mind Medicine (MindMed) Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MMQ Profitability Score
Profitability Due Diligence

Mind Medicine (MindMed) Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

31/100
Profitability
Score

Mind Medicine (MindMed) Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

MMQ Solvency Score
Solvency Due Diligence

Mind Medicine (MindMed) Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
60/100
Solvency
Score

Mind Medicine (MindMed) Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MMQ Price Targets Summary
Mind Medicine (MindMed) Inc

Wall Street analysts forecast MMQ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MMQ is 21.59 EUR with a low forecast of 14.25 EUR and a high forecast of 33.34 EUR.

Lowest
Price Target
14.25 EUR
165% Upside
Average
Price Target
21.59 EUR
302% Upside
Highest
Price Target
33.34 EUR
521% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MMQ?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for MMQ is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Want to learn more about MMQ dividends, buybacks, and debt paydown yield?

Click here to dive deeper.

MMQ Price
Mind Medicine (MindMed) Inc

1M 1M
-6%
6M 6M
-40%
1Y 1Y
+43%
3Y 3Y
-82%
5Y 5Y
+1%
10Y 10Y
+15%
Annual Price Range
5.37
52w Low
2.22
52w High
10.78
Price Metrics
Average Annual Return 142.45%
Standard Deviation of Annual Returns 362.4%
Max Drawdown -97%
Shares Statistics
Market Capitalization 387m EUR
Shares Outstanding 71 872 400
Percentage of Shares Shorted
N/A

Competitive Landscape

Profile

Mind Medicine (MindMed) Inc Logo
Mind Medicine (MindMed) Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

387m EUR

Dividend Yield

0%

Description

Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company is headquartered in New York City, New York. The company went IPO on 2015-05-04. The firm is engaged in developing products to treat brain health disorders. The company is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM-120 is a pharmaceutically optimized form of lysergide D-tartrate that the Company is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

Contact

NEW YORK
New York City
One World Trade Center, Suite 8500
+12122206633
mindmed.co

IPO

2015-05-04

Employees

50

Officers

See Also

Discover More
What is the Intrinsic Value of one MMQ stock?

The intrinsic value of one MMQ stock under the Base Case scenario is 2.74 EUR.

Is MMQ stock undervalued or overvalued?

Compared to the current market price of 5.37 EUR, Mind Medicine (MindMed) Inc is Overvalued by 49%.

Back to Top